Partner with Iktos to identify your next preclinical candidate in less than two years 

Drug Discovery Collaborations

Partner with Iktos to identify your next preclinical candidate in less than two years 

Our Approach

Our integrated approach combines the strengths of Iktos’s AI technologies and robotics automation to deliver innovative drug candidates at unprecedented speed. We work closely with your team to design, synthesize and test compounds towards the perfect candidate, ensuring a seamless and productive collaboration.

Key Technologies seamlessly integrated for more impact

Makya - Generative AI
Spaya - Retrosynthesis AI
Iktos Robotics - Autonomous Lab

Makya - Generative AI

We use our AI to design novel, optimized molecules with high synthetic feasibility matching your Target Product Profile.

Spaya - Retrosynthesis AI

We identify the most efficient synthetic routes for the designed compound to ensure we can rapidly synthesize it.

Iktos Robotics - Autonomous Lab

We use our automated synthesis platform to synthesize the molecule at a very high speed in order to generate real life data as fast as possible for rapid iteration and fast convergence.

Benefits of Collaboration

Benefits of Collaboration
Accelerated Discovery

Accelerated Discovery


Speed up the identification and optimization of new drug candidates.

Enhanced Efficiency

Enhanced Efficiency


Improve success rates and reduce the time and cost of drug discovery.

Innovative Solutions

Innovative Solutions


Leverage cutting-edge AI and robotics to explore unique molecular structures and develop innovative therapies for challenging targets.

Want to know more about expertise & approach ?

Success Stories

Iktos has collaborated with partners in 60+ projects delivering value in real life programs from hit discovery to lead optimization phases. Our in-house pipeline is an example of how fast we are able to progress towards drug candidate in real life.

Target / PathwayTherapeutic AreasHit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
MTHFD2Inflammation auto-immune diseases
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
Confidential TargetOncology
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
Confidential TargetOncology
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate
Confidential TargetImmuno-oncology
Hit DiscoveryHit-to-LeadLead OptimizationPreclinical Candidate

Proven Track Record of
Innovation

Our collaborations have led to the successful identification and optimization of numerous drug candidates. Partner with Iktos to benefit from our proven expertise and advanced technologies.

Get Started

Partner with Iktos to leverage our advanced technologies and expert support.

Contact us to learn more about our Integrated Drug Discovery Collaborations and how we can help accelerate your drug discovery projects.

Partner with Iktos to leverage our advanced technologies and expert support.